Filipa Lynce

38PUBLICATIONS

219CO-AUTHORS

Cancer geneticsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (38)

Sort by Publication Date:

|May 25, 2026

Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies.

|May 14, 2026

Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025.

|Mar 10, 2026

The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.

Natasha B Hunter, Heather A Parsons, Leslie Cope

|Dec 03, 2025

A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2-Mutated Metastatic Breast Cancer.

Filipa Lynce, Noah Graham, Bose S Kochupurakkal

|Sep 30, 2025

Neoadjuvant therapy with eribulin, doxorubicin and cyclophosphamide for patients with HER2-negative inflammatory breast cancer: a phase II study.

Kristina Fanucci, Eren D Yeh, Ruichao Shi

|May 16, 2025

Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

Pageof 7

Frequent Collaborators

11 joint publications

Sara M Tolaney

Ilana Schlam

Claudine Isaacs

Paolo Tarantino

Brittany L Bychkovsky

Ana Garrido-Castro

Rita Nanda

Giuseppe Curigliano

Candace Mainor

Deena Graham

Frequent Collaborators

11 joint publications

Sara M Tolaney

7 joint publications

Ilana Schlam

5 joint publications

Claudine Isaacs

5 joint publications

Paolo Tarantino